|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Gemcitabine versus FLEC Regimen
Given Intra-Arterially to Patients with Unresectable Pancreatic
Cancer: A Prospective, Randomized Phase III Trial of the Italian
Society for Integrated Locoregional Therapy in Oncology J Chemother. 2004 Dec;16(6):589-94. PMID: 15700852
|
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |